(Q34198023)

English

The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survival

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

31 July 2017

The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survival (English)

1 reference

Europe PubMed Central

31 July 2017

0 references

follicular lymphoma

1 reference

based on heuristic

inferred from title

object named as

Elias Campo

13

0 references

Jude Fitzgibbon

20

object named as

Jude Fitzgibbon

1 reference

Europe PubMed Central

31 July 2017

Erlend B. Smeland

11

object named as

Erlend B Smeland

1 reference

Europe PubMed Central

31 July 2017

Randy D Gascoyne

16

object named as

Randy D Gascoyne

1 reference

Europe PubMed Central

31 July 2017

15

object named as

Wing C Chan

1 reference

Europe PubMed Central

31 July 2017

Andreas Rosenwald

8

object named as

Andreas Rosenwald

1 reference

Europe PubMed Central

31 July 2017

10

object named as

Lisa M Rimsza

1 reference

Europe PubMed Central

31 July 2017

Ciarán O'Riain

2

object named as

Ciarán O'Riain

1 reference

Europe PubMed Central

31 July 2017

author name string

Derville O'Shea

1

1 reference

Europe PubMed Central

31 July 2017

Claire Taylor

3

1 reference

Europe PubMed Central

31 July 2017

Rachel Waters

4

1 reference

Europe PubMed Central

31 July 2017

Emanuela Carlotti

5

1 reference

Europe PubMed Central

31 July 2017

Finlay Macdougall

6

1 reference

Europe PubMed Central

31 July 2017

John Gribben

7

1 reference

Europe PubMed Central

31 July 2017

German Ott

9

1 reference

Europe PubMed Central

31 July 2017

Nathalie Johnson

12

1 reference

Europe PubMed Central

31 July 2017

Timothy C Greiner

14

1 reference

Europe PubMed Central

31 July 2017

George Wright

17

1 reference

Europe PubMed Central

31 July 2017

Louis M Staudt

18

1 reference

Europe PubMed Central

31 July 2017

T Andrew Lister

19

1 reference

Europe PubMed Central

31 July 2017

language of work or name

0 references

publication date

15 July 2008

1 reference

Europe PubMed Central

31 July 2017

1 reference

Europe PubMed Central

31 July 2017

112

1 reference

Europe PubMed Central

31 July 2017

3126-3129

1 reference

Europe PubMed Central

31 July 2017

8

1 reference

Europe PubMed Central

31 July 2017

Clinical quantitation of immune signature in follicular lymphoma by RT-PCR-based gene expression profiling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954748

5 July 2018

Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954748

5 July 2018

New treatment options have changed the survival of patients with follicular lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954748

5 July 2018

Tumor suppressor genes in normal and malignant hematopoiesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954748

5 July 2018

Assessing TP53 status in human tumours to evaluate clinical outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954748

5 July 2018

Primer3 on the WWW for general users and for biologist programmers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954748

5 July 2018

The clinical significance of mutations of the P53 tumour suppressor gene in haematological malignancies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954748

5 July 2018

Natural history of and therapy for the indolent non-Hodgkin's lymphomas.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954748

5 July 2018

Structure and function of p53 in normal cells and their aberrations in cancer cells: projection on the hematologic cell lineages

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954748

5 July 2018

Transformation of follicular lymphoma. Expression of p53 and bcl-2 oncoprotein, apoptosis and cell proliferation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954748

5 July 2018

In vivo p53 response and immune reaction underlie highly effective low-dose radiotherapy in follicular lymphoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954748

28 October 2018

Select high-risk genetic features predict earlier progression following chemoimmunotherapy with fludarabine and rituximab in chronic lymphocytic leukemia: justification for risk-adapted therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954748

28 October 2018

Follicular lymphoma international prognostic index.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954748

28 October 2018

The IARC TP53 database: new online mutation analysis and recommendations to users

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954748

28 October 2018

Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954748

28 October 2018

Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954748

28 October 2018

p53 mutation is associated with progression in follicular lymphomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/18628487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Histologic conversion in the non-Hodgkin's lymphomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/18628487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Follicular lymphoma: prognostic factors for response and survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/18628487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation between mutation in P53, p53 expression, cytogenetics, histologic type, and survival in patients with B-cell non-Hodgkin's lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18628487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A limited role for TP53 mutation in the transformation of follicular lymphoma to diffuse large B-cell lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18628487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improvement of overall and failure-free survival in stage IV follicular lymphoma: 25 years of treatment experience at The University of Texas M.D. Anderson Cancer Center

1 reference

https://pubmed.ncbi.nlm.nih.gov/18628487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Follicular Lymphoma International Prognostic Index (FLIPI) separates high-risk from intermediate- or low-risk patients with advanced-stage follicular lymphoma treated front-line with rituximab and the combination of cyclophosphamide, doxorubicin

1 reference

https://pubmed.ncbi.nlm.nih.gov/18628487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Introduction of rituximab in front-line and salvage therapies has improved outcome of advanced-stage follicular lymphoma patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18628487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

p53 mutations are associated with histologic transformation of follicular lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18628487

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1182/BLOOD-2008-05-154013

1 reference

Europe PubMed Central

31 July 2017

1 reference

Europe PubMed Central

31 July 2017

1 reference

Europe PubMed Central

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34198023&oldid=2120383644"